• Biotin-HPDP: Transforming Thiol-Specific Protein Labeling

  2026-07-18

  This thought-leadership article unpacks how Biotin-HPDP empowers translational researchers to interrogate redox-sensitive post-translational modifications, offering both mechanistic insight and strategic guidance. Bridging emerging pain biology with advanced biotinylation chemistry, we explore protocol design, competitive differentiation, and the translational promise of reversible thiol labeling in neurobiology and beyond.

• AM251: Advancing Precision in CB1 Antagonist Translational R

  2026-07-17

  Explore how AM251, a potent CB1 receptor antagonist, empowers translational researchers to dissect endocannabinoid signaling with unprecedented mechanistic clarity. This thought-leadership article integrates mechanistic insights, strategic guidance, and workflow best practices—bridging the gap between foundational neuroscience and translational advances in pain and metabolic disorder research.

• Eclipta prostrata–Hordeum Complex Delays Danazol-Induced Pub

  2026-07-17

  This study demonstrates that a combined extract of Eclipta prostrata and Hordeum vulgare (EHEC) effectively delays precocious puberty in rat models induced by Danazol and high-fat diet. The findings highlight the extract’s potential to modulate the hypothalamic–pituitary–gonadal axis and offer a basis for developing safer alternatives to conventional puberty-suppressing therapies.

• Balsalazide Disodium Dihydrate: Precision Colonic Delivery f

  2026-07-16

  Balsalazide disodium is a water-soluble anti-inflammatory agent and prodrug of 5-aminosalicylic acid, optimized for site-specific activation in the colon. Its mechanism and dosing are validated in ulcerative colitis models and radiotracer workflows, with robust benchmarks for both efficacy and imaging applications.

• Ricin-Induced Bystander Necroptosis in Lung Epithelium: Mech

  2026-07-16

  This study elucidates how ricin toxin triggers bystander necroptosis in lung epithelial cells via inflammatory mediators released from monocytic cells. The findings redefine our understanding of toxin-mediated lung injury and highlight the complex interplay between cell death pathways during severe pulmonary inflammation.

• Refining In Vitro Drug Response Assessment in Cancer Researc

  2026-07-15

  Schwartz’s dissertation introduces a robust distinction between proliferative arrest and cell death metrics in in vitro anti-cancer drug evaluation. By clarifying these measurements, the study offers a more nuanced understanding of drug action mechanisms, improving experimental design and interpretation in cancer research.

• Streptavidin – Cy5: Advancing Biotin Detection in Apoptosis

  2026-07-15

  Streptavidin – Cy5 from APExBIO empowers ultrasensitive, multi-modal detection of biotinylated targets in apoptosis and cancer signaling studies. Its robust fluorescence and high-affinity biotin binding streamline advanced immunohistochemistry and flow cytometry protocols, setting a new standard for reproducibility and signal clarity.

• USP7 Modulates Macrophage Polarization via PKM2 in Acute Pan

  2026-07-14

  This study uncovers how ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis (SAP) through pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. The findings reveal a critical USP7–PKM2 axis that shapes immune responses in SAP, suggesting new therapeutic targets for inflammation modulation.

• AICAR in Action: Protocols and Innovations for AMPK Research

  2026-07-14

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) empowers metabolic disease and inflammation research by enabling precise AMPK pathway activation. This guide delivers step-by-step workflows, troubleshooting strategies, and the translational impact of new reference breakthroughs for robust, reproducible results.

• KR-12 Human Antimicrobial Peptide: Anti-Inflammatory Effects

  2026-07-13

  This study demonstrates that the KR-12 fragment of human cathelicidin exhibits significant anti-inflammatory and antibacterial effects in mouse models of colitis. The findings highlight KR-12's potential as a targeted therapeutic candidate for inflammatory bowel diseases, with mechanistic and translational insights relevant for advanced research.

• 15-PGDH Inhibition Enhances Muscle Repair in GLP-1RA Weight

  2026-07-13

  The reference study identifies inhibition of the prostaglandin-degrading enzyme 15-PGDH as a strategy to preserve and restore skeletal muscle mass and function during GLP-1 receptor agonist–induced weight loss. These findings suggest 15-PGDH inhibition can synergize with metabolic therapies to improve muscle regeneration without compromising the metabolic benefits of anti-obesity drugs.

• Caspase-3 Colorimetric Assay Kit: Practical Workflow Guidanc

  2026-07-12

  The Caspase-3 Colorimetric Assay Kit addresses the need for rapid, quantitative measurement of DEVD-dependent caspase-3 activity—a key biomarker in apoptosis and neurodegeneration research. This kit is best deployed in controlled laboratory settings where specificity for caspase-3 is required; it is not intended for non-apoptotic protease activity or for use in clinical diagnostics.

• Paroxetine Mesylate: Scenario-Driven Best Practices for Lab

  2026-07-10

  This article provides biomedical researchers and lab technicians with evidence-based guidance for using Paroxetine Mesylate (SKU C8698) in cell viability, proliferation, and cytotoxicity assays. Through five real-world laboratory scenarios, it demonstrates how this selective serotonin reuptake inhibitor addresses common workflow challenges, improves data reliability, and offers multi-target advantages validated by quantitative literature. Practical protocol recommendations and product selection tips empower scientists to maximize experimental reproducibility with Paroxetine Mesylate.

• Light-Inducible RNA-Releasing Proteins for Regulated Gene Th

  2026-07-09

  A recent study introduces a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables precise, reversible translational regulation in mammalian cells. This innovation provides a versatile optogenetic gene switch, enhancing the safety and temporal control of gene therapies for chronic metabolic and retinal diseases.

• Necrostatin-1: Advanced Insights into RIP1 Kinase Inhibition

  2026-07-09

  Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, enables mechanistic dissection of necroptosis and informs cutting-edge assay design. This article delivers unique scientific depth on selective allosteric inhibition and the translational impact for tissue injury and cell death modeling.

11414 records 1/761 page Next 12345 下5页 Last page